Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617

Mostrar otras versiones (1)

In this study, it was aimed to investigate$^{149}$Tb-PSMA-617 for targeted α-therapy (TAT) using a mouse model of prostate-specific membrane antigen (PSMA)-expressing prostate cancer.$^{149}$Tb-PSMA-617 was prepared with >98% radiochemical purity (6 MBq/nmol) for the treatment of mice with PSMA-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Umbricht, Christoph A., Gracheva, Nadezda, Johnston, Karl, Schibli, Roger, van der Meulen, Nicholas P., Müller, Cristina, Bernhardt, Peter, Koster, Ulli
Publicado: 2019
Acceso en línea:https://dx.doi.org/10.1038/s41598-019-54150-w
http://cds.cern.ch/record/2702959
Mostrar todas las versiones(2)

Ejemplares similares